OLMAOlema Pharmaceuticals, Inc.

OLMA Stock Price, Valuation & Chart | Olema Pharmaceuticals, Inc.

Compare

$10.830+0.27 (+2.56%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology OLMA intrinsic value OLMA calculated fair value vs price

Overview Financials Dividends Ratios

OLMA Historical price chart

OLMA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization945.97M

PE Ratio-5.36

EPS-2.02

Trading Volume866.27K

Today's High/Low10.99/10.48

Dividend Yield0.00

52 Week High/Low36.26/5.99

Shares Outstanding87.35M

OLMA Financial Statement

OLMA Analyst ratings

OLMA Analysis & performance metrics

OLMA Company profile

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its…

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen…

OLMA Management team

Name

Position

Sean P. Bohen M.D., Ph.D.CEO

President, Chief Executive Officer & Director

Julie Dexter

Senior Vice President & Head of People

David C. Myles Ph.D.

Chief Discovery & Non-Clinical Development Officer

Sasha Austin CPA

Vice President of Finance & Controller

Courtney O'Konek

Vice President of Corporate Communications

Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Shane William Charles Kovacs M.B.A.COO

Chief Operating & Financial Officer

Naseem Zojwalla M.D.

Chief Medical Officer

Name

Position

Sean P. Bohen M.D., Ph.D.CEO

President, Chief Executive Officer & Director

Julie Dexter

Senior Vice President & Head of People

David C. Myles Ph.D.

Chief Discovery & Non-Clinical Development Officer

Sasha Austin CPA

Vice President of Finance & Controller

Courtney O'Konek

Vice President of Corporate Communications

Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Shane William Charles Kovacs M.B.A.COO

Chief Operating & Financial Officer

Naseem Zojwalla M.D.

Chief Medical Officer

Management Team

Sean P. Bohen M.D., Ph.D.CEO

President, Chief Executive Officer & Director

Julie Dexter

Senior Vice President & Head of People

David C. Myles Ph.D.

Chief Discovery & Non-Clinical Development Officer

Sasha Austin CPA

Vice President of Finance & Controller

Courtney O'Konek

Vice President of Corporate Communications

Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Shane William Charles Kovacs M.B.A.COO

Chief Operating & Financial Officer

Naseem Zojwalla M.D.

Chief Medical Officer

Management

Sean P. Bohen M.D., Ph.D.CEO

President, Chief Executive Officer & Director

Julie Dexter

Senior Vice President & Head of People

David C. Myles Ph.D.

Chief Discovery & Non-Clinical Development Officer

Sasha Austin CPA

Vice President of Finance & Controller

Courtney O'Konek

Vice President of Corporate Communications

Shawnte M. Mitchell J.D.

Chief Legal Officer & Corporate Secretary

Shane William Charles Kovacs M.B.A.COO

Chief Operating & Financial Officer

Naseem Zojwalla M.D.

Chief Medical Officer

Total 8 executives

OLMA Frequently asked questions

What is Olema Pharmaceuticals, Inc. (OLMA) Stock Price?

Current stock price of Olema Pharmaceuticals, Inc. (OLMA) stock is $10.830. The stock price is +2.56% higher in the session. The intraday range can be seen from this page. Volume of Olema Pharmaceuticals, Inc. (OLMA) stock is 866.27K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Olema Pharmaceuticals, Inc. (OLMA) stock price going up or down today?

The stock price of Olema Pharmaceuticals, Inc. (OLMA) can change with earnings, company news, and overall market sentiment. Olema Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Olema Pharmaceuticals, Inc. stock expensive at its current price?

Whether Olema Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for OLMA on this page is -5.36. EPS on this page is -2.02. Compare those figures with peers and growth expectations before deciding if the current Olema Pharmaceuticals, Inc. price is justified.

How has the stock price of Olema Pharmaceuticals, Inc. (OLMA) performed historically?

Historical performance for Olema Pharmaceuticals, Inc. (OLMA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how OLMA reacted to past earnings and market events.

Should I buy Olema Pharmaceuticals, Inc. (OLMA) stock, at this price?

Buying Olema Pharmaceuticals, Inc. (OLMA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.